These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 4614297)

  • 21. [Patients with chronic tuberculosis as a problem in tuberculosis control. Information from the central registries of Slovenia and the SAP Vojvodina].
    Zrilić V; Ustar M
    Nar Zdrav; 1976; 32(7-8):296-301. PubMed ID: 1029790
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of controlled clinical trials in chemotherapy of lung tuberculosis].
    Schütz I
    Prax Klin Pneumol; 1987 Mar; 41(3):69-78. PubMed ID: 3295843
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C; Andreis G
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the treatment with reserve drugs of patients excreting drug resistant bacilli, as one solution to the problem of the so-called "chronic cases"].
    Pieniazek J; Martyniak-Murczkiewicz Z; Schnotale J; Waligóra-Antczak R
    Gruzlica; 1968 Oct; 36(10):1050-2. PubMed ID: 5710087
    [No Abstract]   [Full Text] [Related]  

  • 25. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J; Altet Gómez MN
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therizidone in the treatment of chronic pulmonary tuberculosis. (Report of clinical trials)].
    Meo G; Cernetti B; Zordan M
    G Ital Mal Torace; 1969; 23(3):135-48. PubMed ID: 5355950
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
    Bek-Lissner E; Rózewska M
    Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
    [No Abstract]   [Full Text] [Related]  

  • 28. Initial intensive chemotherapy in tuberculosis.
    Prijyanonda B; Subcharoen S; Korkiat K; Chatrapolraks T; Dhumvipat P
    J Med Assoc Thai; 1973 Jul; 56(7):420-5. PubMed ID: 4805906
    [No Abstract]   [Full Text] [Related]  

  • 29. [Efficacy of antitubercular therapy of pulmonary tuberculosis in a hospital outpatient service].
    Warm S
    Gruzlica; 1966 Oct; 34(10):889-95. PubMed ID: 5976986
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
    Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

  • 33. [Causes of the emergence of drug resistance and results of the treatment of tuberculous patients at the Torzym Sanatorium].
    Ryszewski W
    Gruzlica; 1965 Apr; 33(4):277-85. PubMed ID: 5319980
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drip endobronchial administration of complex antitubercular preparations in the treatment of destructive pulmonary tuberculosis].
    Patrikeev GA
    Probl Tuberk; 1975; (6):26-9. PubMed ID: 1215344
    [No Abstract]   [Full Text] [Related]  

  • 35. [Polychemotherapy of bacteriologically positive pulmonary tuberculosis in patients with the treatment duration of over 10 years].
    Panajotović H; Marsenić B
    Plucne Bolesti Tuberk; 1972; 24(1):30-4. PubMed ID: 5045386
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fate of patients with pulmonary tuberculosis and secondary drug resistance to the major drugs].
    Kost A
    Gruzlica; 1969 Nov; 37(11):997-1002. PubMed ID: 5368630
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the problem of patients with chronic tuberculosis in Prague].
    Herold M; Jenicková J; Tousek J; Zatecká J; Matusková E
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):179-86. PubMed ID: 5632316
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness of the treatment of destructive pulmonary tuberculosis].
    Liabakh PP; Mel'nik VN
    Vrach Delo; 1979 Jul; (7):61-3. PubMed ID: 382635
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of prothionamide in the treatment of patients with pulmonary tuberculosis].
    Voĭtova DI; Zaĭtseva TI; Leont'eva GP; Milinder NM; Charikova LP
    Probl Tuberk; 1971; 49(7):24-7. PubMed ID: 5146091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.